RICARDO MENDIONDO: Open Payments
NPI 1124763875 · ALICE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,571 in 76 payments from 19 companies in 2025. Trend: 2023 $51 · 2024 $1,943 · 2025 $1,571
Food & beverage: $1,571
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $266 |
| Lilly USA, LLC | 15 | $206 |
| Merck Sharp & Dohme LLC | 7 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $164 |
| Dexcom, Inc. | 8 | $152 |
| Verona Pharma, Inc. | 1 | $117 |
| GlaxoSmithKline, LLC. | 5 | $93 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Ardelyx, Inc. | 3 | $55 |
Products named: MOUNJARO, Ozempic, Kerendia, VERQUVO, Dexcom G6 Transmitter, Ohtuvayre, TRELEGY ELLIPTA, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
